PON1 anticorps (C-Term)
Aperçu rapide pour PON1 anticorps (C-Term) (ABIN633935)
Antigène
Voir toutes PON1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- PON1 antibody was raised against the C terminal of PON1
-
Purification
- Affinity purified
-
Immunogène
- PON1 antibody was raised using the C terminal of PON1 corresponding to a region with amino acids ASEVLRIQNILTEEPKVTQVYAENGTVLQGSTVASVYKGKLLIGTVFHKA
-
-
-
-
Indications d'application
-
WB: 0.25 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PON1 Blocking Peptide, (ABIN936890), is also available for use as a blocking control in assays to test for specificity of this PON1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PON1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PON1 (Paraoxonase 1 (PON1))
-
Autre désignation
- PON1
-
Sujet
- PON1 hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. It is capable of hydrolyzing a broad spectrum of organophosphate substrates and a number of aromatic carboxylic acid esters. It may mediate an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation.
-
Poids moléculaire
- 39 kDa (MW of target protein)
Antigène
-